pemafibrate
Sponsors
Kowa Research Institute Inc., Toh Ryuji, Iwaki Michihiro, Todo Kenichi, Jaeb Center for Health Research
Conditions
Diabetic Macular EdemaDiabetic RetinopathyHypertriglyceridaemiaIntracranial Atherosclerotic Disease (ICAD)NAFLD with hypertriglyceridemia
NAFLDNoncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver FibrosisStroke (CVA) or TIASymptomatic intracranial arterial stenosis with hypertriglyceridemia
Intracranial Arterial Diseases, Hypertriglyceridemia
Phase 2
Randomized controlled trial of pemafibrate and fenofibrate for NAFLD with hypertriglyceridemia
RecruitingJPRN-jRCTs031200280
Start: 2021-02-16Target: 360Updated: 2026-06-29
A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
Active, not recruitingCTIS2023-508104-38-00
Start: 2023-02-16Target: 16Updated: 2025-04-09
Phase 3
PROMINENT-Eye Ancillary Study (Protocol AD)
TerminatedNCT03345901
Start: 2018-01-15End: 2019-04-03Updated: 2020-09-16
Effect of Pemafibrate and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound
RecruitingJPRN-jRCT1051190122
Start: 2020-03-19Target: 46Updated: 2026-06-29